Continuous local bupivacaine wound infusion with neuraxial morphine reduces opioid consumption after cesarean delivery.

As a part of a quality improvement program, maternal postoperative opioid use and pain scores were compared between those receiving continuous infusion of bupivacaine for local incisional pain control with multimodal pain management and neuraxial morphine versus multimodal pain management with neuraxial morphine alone. We compared postoperative opioid use and pain scores between the multimodal pain management group with neuraxial morphine and the group receiving multimodal pain management, neuraxial morphine, and continuous infusion of bupivacaine for local incisional pain control. A retrospective cohort analysis of cesarean deliveries from January of 2015 through March of 2016 was undertaken.